# The Interplay of Chronic Hepatitis C and COVID-19: Implications for Prognosis and Treatment

**Authors:** Stefan D Lazar, Andreea F Stoenescu, Corneliu Petru Popescu, Simin Florescu, Geta Vancea, Petre Calistru

PMC · DOI: 10.7759/cureus.66639 · Cureus · 2024-08-11

## TL;DR

This study shows that people with chronic hepatitis C who get COVID-19 are at higher risk for severe illness and need careful management.

## Contribution

The study identifies specific risk factors for severe COVID-19 outcomes in patients with chronic hepatitis C.

## Key findings

- Older age, hospitalization in 2021, and respiratory failure were risk factors for severe COVID-19.
- Elevated lactate dehydrogenase levels were linked to more severe disease.
- Detectable hepatitis C virus viremia was associated with worse liver disease.

## Abstract

Introduction

Chronic hepatitis C (CHC) remains a significant public health concern due to both hepatic and extrahepatic manifestations associated with substantial morbidity and mortality. The emergence of SARS-CoV-2 has raised concerns about the outcomes of COVID-19 in CHC patients.

Method

We conducted a retrospective analysis of patients with CHC and SARS-CoV-2 infection admitted to a tertiary care hospital between 2020 and 2023. We performed a global analysis of the entire batch of patients and, later, we evaluated the patients according to the severity of the SARS-CoV-2 infection

Results

The cohort included 89 patients (63 females, 26 males) with a median age of 65 years. Most patients were hospitalized in 2021. Common clinical manifestations included fever, cough, digestive symptoms, and headache. The most frequent comorbidities were renal disease, thyroid disorders, and cancer. Univariate logistic regression analysis identified older age, hospitalization in 2021, and respiratory failure as risk factors for severe COVID-19. Elevated lactate dehydrogenase levels were also associated with an increased risk of severe COVID-19. Regarding CHC, detectable hepatitis C virus viremia was associated with more severe liver disease (p<0.01).

Conclusion

Patients with CHC and SARS-CoV-2 infection have a substantial risk of severe outcomes. Early identification and management of these patients are crucial to improve their prognosis.

## Linked entities

- **Diseases:** chronic hepatitis C (MONDO:0005231), renal disease (MONDO:0005240), cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cough (MESH:D003371), fever (MESH:D005334), headache (MESH:D006261), CHC (MESH:D019698), respiratory failure (MESH:D012131), liver disease (MESH:D008107), cancer (MESH:D009369), COVID-19 (MESH:D000086382), renal disease (MESH:D007674), thyroid disorders (MESH:D013959)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11386413/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11386413/full.md

---
Source: https://tomesphere.com/paper/PMC11386413